The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
Open accessAbstract
SUMMARY Liver cancer epidemiology is changing due to increasing alcohol consumption, rising prevalence of obesity, and advances in hepatitis B virus (HBV) and hepatitis C virus (HCV) treatment. However, the impact of these changes on global liver cancer burden remains unclear. We estimated global and regional temporal trends in the burden of liver cancer and the contributions of various liver disease etiologies using the methodology framework of the Global Burden of Disease study. Between 2010 and 2019, there was a 25% increase in liver cancer deaths. Age-standardized death rates (ASDRs) increased only in the Americas and remained stable or fell in all other regions. Between 2010 and 2019, non-alcoholic steatohepatitis (NASH) and alcohol had the fastest growing ASDRs, while HCV and HBV declined. Urgent measures are required at a global level to tackle underlying metabolic risk factors and slow the growing burden of NASH-associated liver cancer, especially in the Americas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Estes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399
Self-citationProjected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity
Ward, Z. J., Bleich, S. N., Cradock, A. L., Barrett, J. L., Giles, C. M., Flax, C., Long, M. W., & Gortmaker, S. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmsa1909301 · Cited by 2,009
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
Self-citationGlobal Burden of Disease Liver Cancer Collaboration, Akinyemiju, T., Abera, S., Ahmed, M., Alam, N., Alemayohu, M. A., Allen, C., Al-Raddadi, R., Alvis-Guzman, N., Amoako, Y., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3055 · Cited by 1,987
Estes, C., Anstee, Q. M., Arias-Loste, M. T., Bantel, H., Bellentani, S., Caballeria, J., Colombo, M., Craxi, A., Crespo, J., Day, C. P., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.036 · Cited by 1,980
Self-citationGlobal epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00381-6 · Cited by 1,855
Self-citationLoomba, R., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,641
Self-citationSeitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
Younossi, Z., Stepanova, M., Ong, J. P., Jacobson, I. M., Bugianesi, E., Duseja, A., Eguchi, Y., Wong, V. W., Negro, F., Yilmaz, Y., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.05.057 · Cited by 806
Younossi, Z. M., Otgonsuren, M., Henry, L., Venkatesan, C., Mishra, A., Erario, M., & Hunt, S. (2015) · Hepatology · doi:10.1002/hep.28123 · Cited by 802
Paik, J. M., Golabi, P., Younossi, Y., Mishra, A., & Younossi, Z. M. (2020) · Hepatology · doi:10.1002/hep.31173 · Cited by 788
Advancing the global public health agenda for NAFLD: a consensus statement
Lazarus, J. V., Mark, H. E., Anstee, Q. M., Arab, J. P., Batterham, R. L., Castera, L., Cortez-Pinto, H., Crespo, J., Cusi, K., Dirac, M. A., et al. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00523-4 · Cited by 757
Self-citation2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
Le, M. H., Yeo, Y. H., Li, X., Li, J., Zou, B., Wu, Y., Ye, Q., Huang, D. Q., Zhao, C., Zhang, J., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.12.002 · Cited by 711
Self-citationHepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
Dyson, J., Jaques, B., Chattopadyhay, D., Lochan, R., Graham, J., Das, D., Aslam, T., Patanwala, I., Gaggar, S., Cole, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.011 · Cited by 603
Lok, A. S. F., McMahon, B. J., Brown, R. S., Wong, J. B., Ahmed, A. T., Farah, W., Almasri, J., Alahdab, F., Benkhadra, K., Mouchli, M. A., et al. (2016) · Hepatology · doi:10.1002/hep.28280 · Cited by 552
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
Singal, A. G., & El-Serag, H. B. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.08.014 · Cited by 530
Self-citationHepatocellular carcinoma in the setting of alcohol-related liver disease
Ganne-Carrié, N., & Nahon, P. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.008 · Cited by 360
Global Elimination of Chronic Hepatitis
Thomas, D. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1810477 · Cited by 325
Tan, D. J. H., Ng, C. H., Lin, S. Y., Pan, X. H., Tay, P., Lim, W. H., Teng, M., Syn, N., Lim, G., Yong, J. N., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00078-x · Cited by 307
Self-citationHeffernan, A., Cooke, G. S., Nayagam, S., Thursz, M., & Hallett, T. B. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32277-3 · Cited by 265
Progress towards elimination goals for viral hepatitis
Cox, A. L., El-Sayed, M. H., Kao, J.-H., Lazarus, J. V., Lemoine, M., Lok, A. S., & Zoulim, F. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0332-6 · Cited by 198
Julien, J., Ayer, T., Bethea, E. D., Tapper, E. B., & Chhatwal, J. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30062-1 · Cited by 176
Modelling NAFLD disease burden in four Asian regions—2019‐2030
Estes, C., Chan, H. L. Y., Chien, R. N., Chuang, W., Fung, J., Goh, G. B.-B., Hu, T. H., Huang, J., Jang, B. K., Jun, D. W., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15673 · Cited by 175
Huang, D. Q., Li, X., Le, M. H., Le, A. K., Yeo, Y. H., Trinh, H. N., Zhang, J., Li, J., Wong, C., Wong, C. C., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.01.019 · Cited by 142
Self-citationSheron, N. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.006 · Cited by 138
Le, M. H., Yeo, Y. H., Cheung, R. C., Henry, L. L., Lok, A. S.-F., & Nguyen, M. H. (2019) · Hepatology · doi:10.1002/hep.30831 · Cited by 125
Dang, H., Yeo, Y. H., Yasuda, S., Huang, C., Iio, E., Landis, C. S., Jun, D. W., Enomoto, M., Ogawa, E., Tsai, P., et al. (2019) · Hepatology · doi:10.1002/hep.30988 · Cited by 116
Obesity and Alcohol Synergize to Increase the Risk of Incident Hepatocellular Carcinoma in Men
Loomba, R. S., Yang, H., Su, J., Brenner, D. A., Iloeje, U. H., & Chen, C. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.06.027 · Cited by 92
Self-citationRational HCC screening approaches for patients with NAFLD
Singal, A. G., & El-Serag, H. B. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.08.028 · Cited by 80
Self-citationHuang, D. Q., Fowler, K. J., Liau, J., Cunha, G. M., Louie, A. L., An, J. Y., Bettencourt, R., Jung, J., Gitto, Z., Hernandez, C., et al. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16844 · Cited by 58
Self-citationEl‐Serag, H. B., Kanwal, F., Feng, Z., Marrero, J. A., Khaderi, S. A., & Singal, A. G. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.049 · Cited by 57
Self-citationYe, Q., Kam, L. Y., Yeo, Y. H., Dang, N. H., Huang, D. Q., Cheung, R. C., & Nguyen, M. H. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.08.019 · Cited by 57
Self-citationHave incidence rates of liver cancer peaked in the United States?
Petrick, J. L., Florio, A. A., Loomba, R. S., & McGlynn, K. A. (2020) · Cancer · doi:10.1002/cncr.32794 · Cited by 51
Self-citationHepatitis B: Who to treat? A critical review of international guidelines
Huang, D. Q., & Lim, S. G. (2020) · Liver International · doi:10.1111/liv.14365 · Cited by 39
Self-citationDesai, N., Rich, N. E., Jain, M. K., Blackwell, J.-M., Murphy, C. C., Perryman, P., McBryde, J., Quirk, L., Clark, C., Villarreal, D. L., et al. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001085 · Cited by 10
Self-citationNew Advances in Hepatitis B Vaccination for Adults
Huang, Q. D., & Lim, S. G. (2018) · Current Hepatology Reports · doi:10.1007/s11901-018-0435-5 · Cited by 7
Cited by
Singal, A. G., Kanwal, F., & Llovet, J. M. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00825-3 · Cited by 951
Self-citationGlobal epidemiology of cirrhosis — aetiology, trends and predictions
Huang, D. Q., Terrault, N. A., Tacke, F., Gluud, L. L., Arrese, M., Bugianesi, E., & Loomba, R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00759-2 · Cited by 839
Self-citationThe global burden of metabolic disease: Data from 2000 to 2019
Chew, N. W. S., Ng, C. H., Tan, D. J. H., Kong, G., Lin, C., Chin, Y. H., Lim, W. H., Huang, D. Q., Quek, J., Fu, C. E., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.02.003 · Cited by 799
Self-citationCurrent status and future trends of the global burden of MASLD
Miao, L., Targher, G., Byrne, C. D., Cao, Y.-Y., & Zheng, M.-H. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.02.007 · Cited by 781
Changing epidemiology, global trends and implications for outcomes of NAFLD
Wong, V. W.-S., Ekstedt, M., Wong, G. L.-H., & Hagström, H. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.036 · Cited by 765
Metadata
- Authors
- Huang, D. Q., Singal, A. G., Kono, Y., Tan, D. J. H., El-Serag, H. B., & Loomba, R.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2022-07
- Volume
- 34
- Issue
- 7
- Pages
- 969-977.e2
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W4281616850
- Cited by
- 534
- References
- 40
- FWCI
- 56.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.